General Information of the Compound
Compound ID |
CP0062257
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(R)-N-(2-(1-(2-(1-(2-chlorobenzoyl)piperidin-4-yl)ethyl)pyrrolidin-3-ylamino)-2-oxoethyl)-3-(trifluoromethyl)benzamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C28H32ClF3N4O3
|
||||||||||||||||||
Molecular Weight |
565.036
|
||||||||||||||||||
Canonical SMILES |
FC(F)(F)c1cccc(c1)C(=O)NCC(=O)N[C@@H]1CCN(CCC2CCN(CC2)C(=O)c2ccccc2Cl)C1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C28H32ClF3N4O3/c29-24-7-2-1-6-23(24)27(39)36-14-9-19(10-15-36)8-12-35-13-11-22(18-35)34-25(37)17-33-26(38)20-4-3-5-21(16-20)28(30,31)32/h1-7,16,19,22H,8-15,17-18H2,(H,33,38)(H,34,37)/t22-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
UNKSWQVJNKCXOO-JOCHJYFZSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01021, C-C chemokine receptor type 2
Cell Viability or Cytotoxicity Assay